IDX sales and earnings remain solid in 3Q of FY04

Inking a number of contracts and installations helped IDX Systems Corp. maintain revenue and earnings momentum in the third quarter of FY04, ending September 30.

Revenues increased 34 percent to $136.1 million, compared with $101.4 million in the third quarter of FY03. Net income was reported at $9.8 million, compared with a net income of $10.3 million in the year ago quarter.

For the nine-month period, revenues increased 26 percent to $369.0 million, compared with revenues of $292.2 million in the first nine months of FY03. The company recorded a net income of $19.4 million, compared with a net income of $19.4 million in the year-ago period.

Healthcare organizations that signed on with IDX for deployment of its systems and technologies include: the Diagnostic Division of HealthSouth, the University of Minnesota Physicians, Conemaugh Health Initiatives, Middletown Regional Hospital of Middletown, Ohio, and Thomas Jefferson University Hospital of Philadelphia, Pa.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.